干扰素及其在COVID-19患儿中的应用:综述

Chairunnisa Chairunnisa, S. Suharjono
{"title":"干扰素及其在COVID-19患儿中的应用:综述","authors":"Chairunnisa Chairunnisa, S. Suharjono","doi":"10.20885/jif.vol18.iss2.art18","DOIUrl":null,"url":null,"abstract":"Background: All ages, including children, are susceptible to the disease COVID-19. The severity of COVID-19 in children is mild than in adults. One of the recommended antiviral drugs for COVID-19 in children is interferon.\nObjective: To describe the efficacy and safety of using interferon in children with COVID-19\nMethod: The article is a narrative study. The main databases in the article search process in this literature review are PubMed and Google Scholar.\nResults: The articles could potentially be involved in this study were 28 articles. A total of 13 articles included the criteria, 9 articles discussed the use of interferon against respiratory syndrome, 4 articles on interferon in children, and one reference from a literature search.\nConclusion: Interferon therapy in COVID-19 in children has a high cure rate but needs to be evaluated in a larger sample of pediatric patients.","PeriodicalId":32369,"journal":{"name":"Kartika Jurnal Ilmiah Farmasi","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interferons and its use in children with COVID-19: A narrative review\",\"authors\":\"Chairunnisa Chairunnisa, S. Suharjono\",\"doi\":\"10.20885/jif.vol18.iss2.art18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: All ages, including children, are susceptible to the disease COVID-19. The severity of COVID-19 in children is mild than in adults. One of the recommended antiviral drugs for COVID-19 in children is interferon.\\nObjective: To describe the efficacy and safety of using interferon in children with COVID-19\\nMethod: The article is a narrative study. The main databases in the article search process in this literature review are PubMed and Google Scholar.\\nResults: The articles could potentially be involved in this study were 28 articles. A total of 13 articles included the criteria, 9 articles discussed the use of interferon against respiratory syndrome, 4 articles on interferon in children, and one reference from a literature search.\\nConclusion: Interferon therapy in COVID-19 in children has a high cure rate but needs to be evaluated in a larger sample of pediatric patients.\",\"PeriodicalId\":32369,\"journal\":{\"name\":\"Kartika Jurnal Ilmiah Farmasi\",\"volume\":\"38 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kartika Jurnal Ilmiah Farmasi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20885/jif.vol18.iss2.art18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kartika Jurnal Ilmiah Farmasi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20885/jif.vol18.iss2.art18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:包括儿童在内的所有年龄段的人都容易感染COVID-19。COVID-19在儿童中的严重程度比成人轻。儿童COVID-19的推荐抗病毒药物之一是干扰素。目的:探讨干扰素在儿童covid -19治疗中的有效性和安全性。本文献综述文章检索过程中主要使用的数据库为PubMed和Google Scholar。结果:本研究可能涉及的文献有28篇。共有13篇文章纳入了标准,9篇文章讨论了干扰素治疗呼吸综合征的应用,4篇文章讨论了干扰素在儿童中的应用,1篇文献检索。结论:干扰素治疗儿童COVID-19治愈率高,但需要在更大的儿科患者样本中进行评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Interferons and its use in children with COVID-19: A narrative review
Background: All ages, including children, are susceptible to the disease COVID-19. The severity of COVID-19 in children is mild than in adults. One of the recommended antiviral drugs for COVID-19 in children is interferon. Objective: To describe the efficacy and safety of using interferon in children with COVID-19 Method: The article is a narrative study. The main databases in the article search process in this literature review are PubMed and Google Scholar. Results: The articles could potentially be involved in this study were 28 articles. A total of 13 articles included the criteria, 9 articles discussed the use of interferon against respiratory syndrome, 4 articles on interferon in children, and one reference from a literature search. Conclusion: Interferon therapy in COVID-19 in children has a high cure rate but needs to be evaluated in a larger sample of pediatric patients.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信